Evolution of HLA Antibody Detection: Technology Emulating Biology

1 January 2004

journal article
review article
Published by Springer Nature in Immunologic Research

Vol. 29 (1-3) , 041-054
https://doi.org/10.1385/ir:29:1-3:041

Abstract

New technological advances in the field of histocompatibility have provided an approach to systematically address the specificity of positive lymphocyte crossmatches. These approaches can now confirm whether a positive crossmatch is (or is not) due to class I and/or class II antibodies directed against donor HLA antigens. The information gained from the application of these sensitive and specific technologies can be used to predict crossmatch results for highly sensitized patients. In summary, these emerging technologies have provided the tools to reliably determine the clinical relevance of a positive lymphocyte crossmatch.

Keywords

This publication has 33 references indexed in Scilit:

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm
Human Immunology, 2002
IMPROVED FLOW CYTOMETRIC DETECTION OF HLA ALLOANTIBODIES USING PRONASE
Transplantation, 2001
Simultaneous HLA Class I and Class II Antibodies Screening with Flow Cytometry
Human Immunology, 1998
CLINICAL AND ECONOMIC IMPACT OF FLOW CYTOMETRY CROSSMATCHING IN PRIMARY CADAVERIC KIDNEY AND SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENTS1
Transplantation, 1997
Alloantigen processing and presentation.
1995
THE FLOW CYTOMETRIC CROSSMATCH AND EARLY RENAL TRANSPLANT LOSS
Transplantation, 1990
ANTIGENIC SPECIFICITY OF ANTIBODY REACTIVE IN THE ANTIGLOBULIN-AUGMENTED LYMPHOCYTOTOXICITY TEST
Transplantation, 1982
Detection of Alloantibodies Using a Sensitive Antiglobulin Microcytotoxicity Test: Identification of Low Levels of Pre‐Formed Antibodies in Accelerated Allograft Rejection
Tissue Antigens, 1972
Hyperacute Renal-Homograft Rejection in Man
New England Journal of Medicine, 1968
HYPERACUTE REJECTION OF KIDNEY ALLOGRAFTS, ASSOCIATED WITH PRE-EXISTING HUMORAL ANTIBODIES AGAINST DONOR CELLS
The Lancet, 1966